BioXcel Therapeutics
BTAI
BTAI
36 hedge funds and large institutions have $32.6M invested in BioXcel Therapeutics in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 2 closing their positions.
Holders
36
Holders Change
+16
Holders Change %
+80%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
10
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$3.28M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$2.84M |
3 |
3
State Street
Boston,
Massachusetts
|
$526K |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$662K |
5 |
5
Squarepoint
New York
|
$352K |